PloS one

BMJ open

Haematologica

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

[1] Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.

[2] pre/post-treatment dynamic of inflammatory markers has prognostic value in patients with small hepatocellular carcinoma managed by stereotactic body radiation therapy

[3] Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study.

[4] A systematic review of medicinal plants used against Echinococcus granulosus.

[5] Impact of red blood cell transfusion dose density on progression-free survival in lower-risk myelodysplastic syndromes patients.

[6] Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

[7] determinants of overall and progression-free survival of nigerian patients with philadelphia-positive chronic myeloid leukemia

[8] progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer